KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review

BACKGROUND: Epidermal growth factor receptor (EGFR) signaling is one of the most promising targets for molecular-targeted therapies in esophageal squamous cell carcinoma (ESCC). Thus, the molecular diagnosis of KRAS and BRAF mutations is clinically important in therapeutic decision making. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigaki, Hironobu, Baba, Yoshifumi, Watanabe, Masayuki, Miyake, Keisuke, Murata, Asuka, Iwagami, Shiro, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Yoshida, Naoya, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Translational Research and Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853643/
https://www.ncbi.nlm.nih.gov/pubmed/23274581
http://dx.doi.org/10.1245/s10434-012-2819-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853643/
https://www.ncbi.nlm.nih.gov/pubmed/23274581
http://dx.doi.org/10.1245/s10434-012-2819-z

Ejemplares similares